Table 2.

The forward MR analysis on TL and the classification NHL

Outcome	nSNP	Methods	P value∗	OR	CI (95%)	P (heterogeneity)		P (pleiotropy)	MR-PRESSO
						MR-Egger	IVW
Follicular lymphoma	108	MR-Egger	0.736	1.132	0.550–2.333	0.068	0.073	0.547	0.083
		WM	0.266	1.439	0.749–2.763
		IVW	0.151	1.358	0.894–2.062
Nonfollicular lymphoma	110	MR-Egger	0.006	1.825	1.198–2.781	0.730	0.737	0.419	0.722
		WM	0.011	1.666	1.138–2.439
		IVW	1.98E−4	1.583	1.243–2.016
Diffuse large B-cell lymphoma	109	MR-Egger	0.029	2.129	1.089–4.163	0.791	0.789	0.309	0.807
		WM	0.072	1.750	0.947–3.234
		IVW	0.017	1.599	1.086–2.354
Waldenström macroglobulinemia, lymphoplasmacytic lymphoma	110	MR-Egger	0.068	10.264	0.861–122.364	0.068	0.077	0.894	0.075
		WM	0.081	6.529	0.842–50.606
		IVW	0.002	8.940	2.165–36.922
Mantle cell lymphoma	110	MR-Egger	0.538	1.608	0.357–7.256				0.743
		WM	0.549	1.582	0.360–6.956	0.740	0.743	0.358
		IVW	0.017	2.874	1.209–6.835
Marginal zone B-cell lymphoma	109	MR-Egger	0.899	1.110	0.222–5.559	0.227	0.243	0.639	0.250
		WM	0.848	0.864	0.190–3.916
		IVW	0.653	0.809	0.321–2.038
Mature T/NK-cell lymphomas	110	MR-Egger	0.579	1.391	0.434–4.460				0.379
		WM	0.510	0.709	0.240–2.097	0.465	0.382	0.044
		IVW	0.057	0.517	0.262–1.019
Other and unspecified types of NHL	110	MR-Egger	0.324	1.387	0.726–2.651	0.907	0.915	0.594	0.915
		WM	0.338	1.349	0.731–2.490
		IVW	0.013	1.603	1.105–2.325

^∗Bold values indicate significant results.